SkinHealth Systems Inc. (SKIN)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 119 | 260 | 366 | 398 | 334 | 301 | 290 | 285 |
| Operating profit | $m | -21 | -4 | ||||||
| Net profit | $m | -29 | -379 | 44 | -100 | -29 | -10 | -28 | -24 |
| EPS reported | $ | -0.16 | -0.22 | ||||||
| Operating cashflow per share | $ | 0.30 | 0.17 | ||||||
| Capex per share | $ | 0.04 | 0.04 | ||||||
| FCF per share | $ | 0.26 | 0.13 | ||||||
| Free cash flow | $m | 32 | 17 | ||||||
| Net debt | $m | 137 | 139 | ||||||
| Book value equity | $m | 61 | 56 | ||||||
| Book value per share | $ | 0.45 | 0.43 | ||||||
| Number of shares | m | 135.8 | 129.6 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.88 | 3.16 | ||||||
| P/S LTM | x | 0.58 | 0.61 | ||||||
| P/FCF LTM | x | 5.43 | 10.56 | ||||||
| EV/EBITDA LTM | x | 8.30 | 11.13 | ||||||
| EV/Sales LTM | x | 1.07 | 0.85 | ||||||
| Earnings Yield LTM | % | -5.42% | -32.86% | ||||||
| FCF Yield | % | +18.40% | +9.47% | ||||||
| Quality | |||||||||
| ROE | % | -15.58% | -47.84% | ||||||
| ROIC | % | -4.70% | -1.01% | ||||||
| Operating margin | % | -6.92% | -1.49% | ||||||
| Gross margin | % | +65.28% | +66.34% | ||||||
| FCF/Sales | % | +10.75% | +5.74% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -10.02% | -13.24% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +246.06% | +78.16% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.09 | 0.05 | ||||||
| Net Debt/EBITDA | x | 3.77 | 5.57 | ||||||
| EBIT/Net interest | x | -1.08 | -0.17 | ||||||
| Net debt/market cap | % | +2.10% | +3.99% | ||||||
| Net debt/Equity | x | 2.24 | 2.50 | ||||||
| Gross debt/equity | x | 6.20 | 6.60 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free